DDX17 and chronic obstructive pulmonary disease: Moreover, we lack experimental validation in clinical COPD patients sample, and the relationship between FOXO1 and DDX17 and symptomseverity, quality of life, and frequencyof acute exacerbations in COPD remains to be confirmed.